Great Novel Therapeutics Biotech & Medicals Total Assets

As of the most recent data (June 2026), 7427.TWO shows a total assets of $780M. That compares with $590M in the prior-year period — up 33.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 7427.TWO's total assets is now $780M (was $590M) — a 33.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Great Novel Therapeutics Biotech & Medicals is outperforming or lagging.

Tracking 7427.TWO's total assets over time shows whether Great Novel Therapeutics Biotech & Medicals is scaling, shrinking, or reshaping that part of the business. The current reading is $780M That compares with $590M in the prior-year period — up 33.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Great Novel Therapeutics Biotech & Medicals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $780M) with ownership activity and broader fundamentals.

Great Novel Therapeutics Biotech & Medicals's total assets is $780M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.